High inpatient dose of opioid at discharge compared to home dose predicts readmission risk in sickle cell disease
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Hematology"
DOI: 10.1002/ajh.25311
Abstract: REFERENCES 1. U.S. Cancer Stat Working Group. U.S. Department of Health and Human Services. U.S. Cancer Stat Data Visualizations Tool, based on November 2017 submission data: www.cdc.gov/cancer/dataviz, June 2018. Accessed August 5, 2018. 2. Kumar… read more here.
Keywords: inpatient dose; myeloma; high inpatient; multiple myeloma ... See more keywords